EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Apolipoprotein C1 and apoprotein E as potential therapeutic and prognostic targets for adrenocortical carcinoma

Shaojin Li, Shuixiu Xiao, Yongli Situ iD

Cancer Biomarkers · 2025

DOI: 10.1177/18758592241308440 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biomarkers, 2025. Verfasst von Shaojin Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical laboratory, Shenzhen Longhua District Central Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: Adrenocortical Carcinoma, Apolipoprotein C-I, Apolipoproteins E, Adrenal Cortex Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: postdoctoral Foundation of Guangdong Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Apolipoprotein C1 ( APOC1) and Apoprotein E (APOE) play important roles in lipid transport and metabolism. In recent years, APOC1 and APOE have been shown to play key roles in the occurrence and development of various cancers. However, the expression levels, gene regulatory networks, prognostic values, and target predictions of APOC1 and APOE in adrenocortical carcinoma (ACC) remain unclear.

Methods

Various bioinformatics analysis methods were used, including gene expression profiling interactive analysis, the University of Alabama at Birmingham cancer data analysis portal, biomarker exploration of solid tumors software, the BioPortal for Cancer Genomics, search tool for the retrieval of interacting genes/proteins, gene multiple association network integration algorithm, Metascape, transcriptional regulatory relationships unraveled by sentence-based text-mining, LinkedOmics, and genomics of drug sensitivity in cancer analysis.

Results

APOC1 and APOE expression were strongly downregulated in patients with ACC. APOC1 and APOE expression levels were lower in male patients with ACC than those in female patients. Furthermore, APOC1 and APOE expression levels affected the prognosis of patients with ACC. The main functions of APOC1 and its altered neighboring genes (ANG) were organophosphate ester transport, rRNA processing, and positive regulation of cytokine production. Cytolysis, protein ubiquitination, and histone modification were the main functions of APOE and its ANGs. The transcription factor E2F1, tumor protein p53, miR-182, miR-493, Erb-B2 receptor tyrosine kinase 2, and cyclin dependent kinase 1 were key regulatory targets of APOC1 , APOE , and the ANGs. APOC1 and APOE expression in patients with ACC were positively associated with immune cell infiltration . Furthermore, anti-programmed cell death protein 1 immunotherapy strongly downregulated the expression of APOC1 in patients with ACC. Both pilaralisib and elesclomol strongly inhibited SW13 cell growth.

Conclusions

This study preliminarily clarified that APOC1 and APOE might be potential therapeutic and prognostic targets for ACC, and identified new targets and treatment strategies for ACC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenocortical CarcinomaApolipoprotein C-IApolipoproteins EAdrenal Cortex NeoplasmsBiomarkers, TumorHumansPrognosisFemaleMaleComputational BiologyGene Expression Regulation, NeoplasticGene Expression ProfilingGene Regulatory Networks

Stichwörter der Autor:innen

APOC1APOEadrenocortical carcinomagene regulation networktarget prediction

Substanzen

Apolipoprotein C-IApolipoproteins EBiomarkers, TumorApoE protein, humanAPOC1 protein, human

Autor:innen und Institutionen

  • Clinical laboratory, Shenzhen Longhua District Central Hospital, Shenzhen, China.
  • Department of Gynecology, Shenzhen Longhua District Central Hospital, Shenzhen, China.
  • Department of Parasitology, Guangdong Medical University, Zhanjiang, China.

ORCID-Profile: Yongli Situ

Förderung

  • postdoctoral Foundation of Guangdong Medical University

Zitieren

APA

Li, S., Xiao, S., & Situ, Y. (2025). Apolipoprotein C1 and apoprotein E as potential therapeutic and prognostic targets for adrenocortical carcinoma. Cancer Biomarkers. https://doi.org/10.1177/18758592241308440

Vancouver

Li S, Xiao S, Situ Y. Apolipoprotein C1 and apoprotein E as potential therapeutic and prognostic targets for adrenocortical carcinoma. Cancer Biomarkers. 2025. doi:10.1177/18758592241308440

BibTeX
@article{Li2025,
  author = {Li, Shaojin and Xiao, Shuixiu and Situ, Yongli},
  title = {Apolipoprotein C1 and apoprotein E as potential therapeutic and prognostic targets for adrenocortical carcinoma},
  journal = {Cancer Biomarkers},
  year = {2025},
  doi = {10.1177/18758592241308440}
}
Kostenlos starten →